The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I study of intratumoral injection of ipilimumab and interleukin-2 in patients with unresectable stage III-IV melanoma.
 
Randy Christopher Bowen
Stock and Other Ownership Interests - StreamDx
Patents, Royalties, Other Intellectual Property - StreamDx
 
Stephanie Meek
No Relationships to Disclose
 
Matthew Williams
No Relationships to Disclose
 
Kenneth F. Grossmann
Consulting or Advisory Role - Roche/Genentech
 
Robert Hans Ingemar Andtbacka
Consulting or Advisory Role - Amgen
Speakers' Bureau - Novartis
Research Funding - Amgen (Inst); Viralytics (Inst)
 
Tawnya Lynn Bowles
Research Funding - GlaxoSmithKline (Inst); Polynoma (Inst)
 
John Robert Hyngstrom
Consulting or Advisory Role - Castle Biosciences
 
Sancy Ann Leachman
Honoraria - Myriad Genetics
Consulting or Advisory Role - Myriad Genetics
 
Douglas Grossman
No Relationships to Disclose
 
Sheri L Holmen
No Relationships to Disclose
 
Matthew W VanBrocklin
No Relationships to Disclose
 
Hung T. Khong
Stock and Other Ownership Interests - Array BioPharma; Exelixis
Research Funding - Celgene (Inst)
Patents, Royalties, Other Intellectual Property - University of South Alabama (Inst)